IBOS

Integration of Biosynthesis and Organic Synthesis.

Duration
2003 – 2012

Aim
IBOS (Integration of Biosynthesis and Organic Synthesis) aims at a change of strategy in synthetic chemistry by integrating state of the art organic chemistry and modern biochemistry and biotechnology. This will enable a new and sustainable future for more efficient industrial synthesis of ever more complex products, hand in hand with a drastic reduction of waste products.

Theme
The programme focuses on the following research lines:
• Molecular Biology & Biosynthesis
• Bio-transformations
• Bio-inspired Organic Synthesis
• Bioprocess Engineering

Budget
M€ 13,6

Financing
NWO (M€ 4,54: NWO General Board M€ 2,27 and NWO Chemical Sciences M€ 2,27), Ministry of Economic Affairs (M€ 4,54), chemical and life sciences industry (M€ 4,54)

Partners
DSM, MSD, Friesland Foods, Solvay Pharmaceuticals, ICI (AkzoNobel), Syncom, Synthon, Applikon, Sanquin Reagents, Chiralix, ProSensa, CLEA Technologies, Dafra Pharma International, Encapson, SyMO-Chem, Isobionics, Enzyscreen, ProteoNic

Background
More about IBOS